HIV
Top Ten most popular articles on Pharmafile.com this week
September 29, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, EMA, FDA, HIV, J&J, JJ, Kevzara, Mylan, NICE, Sanofi, nash, top ten
It’s Friday, and it’s time for another round up of the most popular articles on pharmafile.com over the last seven …
Rates of HIV rise amongst older population
September 28, 2017Medical Communications HIV, HIV test, biotech, drugs, pharma, pharmaceutical
It is rare to hear bad news in the fight against the spread of HIV, with the global campaign against …
New therapy offers triple threat to HIV virus
September 22, 2017Medical Communications, Research and Development HIV, Sanofi, biotech, drugs, pharma, pharmaceutical
Sanofi and the National Institutes of Health (NIH) have combined to create a potential HIV therapy that was shown to …
Anti-HIV drug PrEP proves safety in gay and bisexual adolescents
September 6, 2017Research and Development Gilead, HIV, Pharamceuticals, PrEP, Truvada, health, medicine, pharma
A new study has found that pre-exposure prophylaxis (PrEP) drugs such as Gilead’s Truvada (emtricitabine/tenofovir disoproxil fumarate), which pre-emptively protects …
HIV home tests seized from market over potential risk
August 24, 2017Sales and Marketing HIV, MHRA, biotech, drugs, pharma, pharmaceutical
The MHRA has removed over 100 HIV home testing kits from two UK based suppliers, after they were found not …
HIV-screening by GPs could reduce incidence and cost
July 31, 2017Sales and Marketing GP, HIV, NHS, biotech, drugs, pharma, pharmaceutical
Researchers have found that offering first-time patients a HIV test in an area of high-prevalence could help reduce levels of …
Janssen single tablet regimen shows Phase 3 success in HIV
July 26, 2017Research and Development HIV, Janssen, biotech, healthcare, pharma, pharmaceuticals
The latest Phase 3 data investigating Janssen’s darunivir in the treatment of human immunodeficiency virus (HIV-1) showed that the drug …
Monthly injectable HIV treatment proves as effective as traditional daily pill regimen
July 24, 2017Research and Development, Sales and Marketing AIDS, HIV, Janssen, ViiV Healthcare, biotech, drugs, pharma, pharmaceuticals
New early trial data suggests that current daily HIV pill regimens could be replaced with injections which slowly release medication …
Contaminated blood inquiry to probe thousands of deaths
July 12, 2017Medical Communications, Research and Development HCV, HIV, biotech, drugs, haemophilia, pharma, pharmaceutical
UK Government has announced that it will launch an inquiry to discover how 4,670 people were given blood infected by …
Gilead to launch injunction against Mylan and Actavis over HIV generics in Ireland
July 6, 2017Sales and Marketing Actavis, Gilead, HIV, Mylan, Truvada
Gilead is expected to launch injunctive action against rivals Mylan and Actavis over the allegation that they are planning to …
HIV cases in gay men fall for the first time in England
June 23, 2017Medical Communications HIV, PrEP
For the first time in English history, new diagnoses of HIV have fallen across the country – the drop was …
Inovio posts “exceptional” results for HIV vaccine
May 25, 2017Research and Development AIDS, HIV, HIV vaccine, Vaccine
Inovio Pharmaceuticals has been working on HIV vaccines for a long time and, eight years after signing a $25 million …
HIV life expectancy boosted 10 years by new drugs
May 11, 2017Research and Development HIV
The latest research to emerge from authors of the University of Bristol has revealed that those living with HIV can …
Cipla halts HIV drug production due to delayed government funding
March 6, 2017Sales and Marketing Cipla, HIV, India, Lopinavir
Indian pharmaceutical company Cipla has halted production of its child-friendly antiretroviral HIV treatment Lopinavir (ABT-378) due to the failure by …
Cuba begins Phase 1 testing of HIV vaccine
February 27, 2017Research and Development, Sales and Marketing Cuba, HIV
Cuba has announced that it has begun testing a HIV vaccine that looks to reduce the ‘payload’ of the virus …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
